Health Care & Life Sciences » Biotechnology | Sangui Biotech International Inc.

Sangui Biotech International Inc. | Balance Sheet

Fiscal year is July-June. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
36.70
71.70
15.90
63.10
50.00
17.90
Total Accounts Receivable
332.10
71.70
15.30
9.00
8.90
49.90
Other Current Assets
33.10
47.00
33.50
27.30
23.40
19.50
Total Current Assets
402.00
190.30
64.70
99.40
82.20
87.40
Net Property, Plant & Equipment
0.30
-
-
-
-
-
Other Assets
-
-
44.90
-
-
-
Total Assets
402.30
190.30
109.60
99.40
82.20
87.40
ST Debt & Current Portion LT Debt
15.00
-
177.30
134.20
134.30
Accounts Payable
132.10
138.30
128.20
180.40
165.60
Other Current Liabilities
27.20
46.70
109.20
7.60
10.70
Total Current Liabilities
174.40
185.00
414.60
322.20
310.60
Total Liabilities
174.40
185.00
414.60
322.20
310.60
Common Equity (Total)
510.20
377.70
200.80
306.10
304.90
Total Shareholders' Equity
510.20
377.70
200.80
306.10
304.90
Total Equity
228.00
5.30
305.00
222.80
228.40
Liabilities & Shareholders' Equity
402.30
190.30
109.60
99.40
82.20
Accumulated Minority Interest
282.30
372.40
505.80
528.90
533.30

About Sangui Biotech International

View Profile
Address
Alfred Herrhausen Street 44
Witten Nordrhein-Westfalen 58455
Germany
Employees -
Website http://www.sanguibiotech.com
Updated 07/08/2019
Sangui Biotech International, Inc. is a holding company to its subsidiaries which has a purpose of securing financial and access to the capital markets. It engages in the manufacture of wound treatment and cosmetic products as well as licensing partners in doing the same business. The company was founded in 1995 and is headquartered in Witten, Germany.